Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Prelude Therapeutics Inc | 230,000 | reported | 04 Feb 2026 | tx 39+945,000−120,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Feb 2026 | GRANT_AWARD | Prelude Therapeutics Inc | 230,000 | 0.00 USD | deriv |
| 04 Feb 2025 | GRANT_AWARD | Prelude Therapeutics Inc | 175,000 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Prelude Therapeutics Inc | 150,000 | 0.00 USD | deriv |
| 07 Feb 2023 | GRANT_AWARD | Prelude Therapeutics Inc | 135,000 | 0.00 USD | deriv |
| 15 Feb 2022 | GRANT_AWARD | Prelude Therapeutics Inc | 100,000 | 0.00 USD | deriv |
| 26 Aug 2021 | SALE | Prelude Therapeutics Inc | 1,700 | 35.19 USD | |
| 27 Aug 2021 | SALE | Prelude Therapeutics Inc | 607 | 37.08 USD | |
| 26 Aug 2021 | EXERCISE | Prelude Therapeutics Inc | 1,700 | 1.43 USD | |
| 27 Aug 2021 | EXERCISE | Prelude Therapeutics Inc | 6,014 | 1.43 USD | |
| 27 Aug 2021 | SALE | Prelude Therapeutics Inc | 2,700 | 35.32 USD | |
| 27 Aug 2021 | SALE | Prelude Therapeutics Inc | 2,707 | 36.23 USD | |
| 26 Aug 2021 | EXERCISE | Prelude Therapeutics Inc | 1,700 | 0.00 USD | deriv |
| 27 Aug 2021 | EXERCISE | Prelude Therapeutics Inc | 6,014 | 0.00 USD | deriv |
| 13 Aug 2021 | EXERCISE | Prelude Therapeutics Inc | 1,728 | 1.43 USD | |
| 13 Aug 2021 | EXERCISE | Prelude Therapeutics Inc | 558 | 1.89 USD | |
| 13 Aug 2021 | SALE | Prelude Therapeutics Inc | 2,286 | 35.07 USD | |
| 13 Aug 2021 | EXERCISE | Prelude Therapeutics Inc | 558 | 0.00 USD | deriv |
| 13 Aug 2021 | EXERCISE | Prelude Therapeutics Inc | 1,728 | 0.00 USD | deriv |
| 27 Jul 2021 | SALE | Prelude Therapeutics Inc | 19,320 | 35.45 USD | |
| 27 Jul 2021 | SALE | Prelude Therapeutics Inc | 680 | 36.09 USD | |
| 27 Jul 2021 | EXERCISE | Prelude Therapeutics Inc | 20,000 | 1.43 USD | |
| 27 Jul 2021 | EXERCISE | Prelude Therapeutics Inc | 20,000 | 0.00 USD | deriv |
| 20 Jul 2021 | GRANT_AWARD | Prelude Therapeutics Inc | 95,000 | 0.00 USD | deriv |
| 07 May 2021 | EXERCISE | Prelude Therapeutics Inc | 10,000 | 1.43 USD | |
| 07 May 2021 | SALE | Prelude Therapeutics Inc | 200 | 41.85 USD |